Why are there different versions of the Oswestry Disability Index?

A review

Jeremy C. T. Fairbank M.D., F.R.C.S.
View More View Less
  • Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford, United Kingdom
Restricted access

Purchase Now

USD  $45.00

Spine - 1 year subscription bundle (Individuals Only)

USD  $369.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

This article updates readers on the current state of the Oswestry Disability Index (ODI) and the impact of unvalidated versions. The ODI is now licensed to the Mapi Research Trust in order to preserve a standard version in English and in validated translations. A proposed threshold of “normality” is potentially helpful as an outcome for both audit and research. There is an application of the sex section as a quality measure in Germany.

The ODI is an important international shared resource for clinicians and investigators and should not be abused. Its current status will not be enhanced by further modification. It is now registered with the International Consortium for Health Outcomes Measurement as a standard outcome measure.

Abbreviations used in this paper:MRC = Medical Research Council; ODI = Oswestry Disability Index.

Spine - 1 year subscription bundle (Individuals Only)

USD  $369.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address correspondence to: Jeremy C. T. Fairbank, M.D., F.R.C.S., St. Lukes, Latimer Rd., Oxford OX3 7PF, United Kingdom. email: jeremy.fairbank@ndorms.ox.ac.uk.

Please include this information when citing this paper: published online November 8, 2013; DOI: 10.3171/2013.9.SPINE13344.

  • 1

    Davidson M: Rasch analysis of three versions of the Oswestry Disability Questionnaire. Man Ther 13:222231, 2008

  • 2

    Fairbank J: Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine (Phila Pa 1976) 32:29292931, 2007. (Letter)

    • Search Google Scholar
    • Export Citation
  • 3

    Fairbank JC, , Couper J, , Davies JB, & O'Brien JP: The Oswestry low back pain disability questionnaire. Physiotherapy 66:271273, 1980

  • 4

    Fairbank JC, & Pynsent PB: The Oswestry Disability Index. Spine (Phila Pa 1976) 25:29402952, 2000

  • 5

    Fairbank JC, , Van Hooff M, & Mannion AF: Determination of the Oswestry Disability Index (ODI) score equivalent to a "satisfactory symptom state.". Eur Spine J 22:Suppl 1 S55, 2013. (Abstract)

    • Search Google Scholar
    • Export Citation
  • 6

    Mannion AF, , Porchet F, , Kleinstück FS, , Lattig F, , Jeszenszky D, & Bartanusz V, : The quality of spine surgery from the patient's perspective. Part 1: the Core Outcome Measures Index in clinical practice. Eur Spine J 18:Suppl 3 367373, 2009

    • Search Google Scholar
    • Export Citation
  • 7

    Miekisiak G, , Kollataj M, , Dobrogowski J, , Kloc W, , Libionka W, & Banach M, : Validation and cross-cultural adaptation of the Polish version of the Oswestry Disability Index. Spine (Phila Pa 1976) 38:E237E243, 2013

    • Search Google Scholar
    • Export Citation
  • 8

    Roland M, & Fairbank J: The Roland-Morris Disability Questionnaire and the Oswestry Disability Questionnaire. Spine (Phila Pa 1976) 25:31153124, 2000

    • Search Google Scholar
    • Export Citation
  • 9

    van Hooff ML, , Spruit M, , O'Dowd JK, , van Lankveld W, , Fairbank JC, & van Limbeek J: Predictive factors for successful clinical outcome 1 year after an intensive combined physical and psychological programme for chronic low back pain. Eur Spine J [epub ahead of print] 2013

    • Search Google Scholar
    • Export Citation
  • 10

    Zigler JE, & Delamarter RB: Five-year results of the prospective, randomized, multicenter, Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential arthrodesis for the treatment of single-level degenerative disc disease. Clinical article. J Neurosurg Spine 17:493501, 2012

    • Search Google Scholar
    • Export Citation
  • 11

    Zigler JE, , Glenn J, & Delamarter RB: Five-year adjacent-level degenerative changes in patients with single-level disease treated using lumbar total disc replacement with ProDisc-L versus circumferential fusion. Clinical article. J Neurosurg Spine 17:504511, 2012

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 954 698 64
Full Text Views 816 72 9
PDF Downloads 693 35 6
EPUB Downloads 0 0 0